Latest ProteoGenix News & Updates

See the latest news and media coverage for ProteoGenix. We track all announcements, press releases, and industry mentions in real time, all in one place.

ProteoGenix

Supplier of life science reagents and custom services

proteogenix-products.com

Headquarters: Schiltigheim, France
Founded year: 2003
Company type: Private company
Number of employees: 10–60

Last updated Today

Latest news about ProteoGenix

In short: ProteoGenix expanded its diagnostic partnerships and AI-driven antibody capabilities while facing media reports of alleged state aid fraud.

Company announcements

April 7 ProteoGenix

ProteoGenix de-risks antibody humanization with AI-guided design

They humanized a French biotech's lead antibody for cervical cancer therapy, reducing immunogenicity risk and improving binding up to 2.6-fold in 3 weeks.

March 27 ProteoGenix

ProteoGenix partners with MicrosensDx on sepsis diagnostic

They design antibodies distinguishing protein isoforms for the ox-PTX3 ELISA test. Promising results achieved; scaling to clinical trials.

March 26 ProteoGenix

ProteoGenix powers groundbreaking endometriosis research

They collaborated with Fondazione Italiana Endometriosi and Prof. Pietro Giulio Signorile to deliver the antibody discovery pipeline for patent WO2025062271A1 targeting NTRK2.

March 17 ProteoGenix

ProteoGenix accelerates neurology diagnostics with AI-driven antibody affinity maturation

They boosted a mouse antibody's binding affinity 20-fold for neurodegenerative disease detection using paratope-epitope mapping, AI-guided mutations, and wet-lab validation.

Media coverage

April 9 Cambridge Independent

MicrosensDx works with ProteoGenix to enhance diagnostic sepsis test

MicrosensDx is partnering with French biotech ProteoGenix to accelerate its diagnostic sepsis test towards clinical ...

March 23 360dx

MicrosensDx, ProteoGenix Partner for Sepsis Biomarker Test Development

The firms, based in the UK and in France, are collaborating to develop an ELISA assay for a novel biomarker of severe sepsis known as...

30 December 2024 DNA

Schiltigheim In the middle of Covid, the boss was making fakes to benefit from state aid

The president of Proteogenix, a biotechnology company based in Schiltigheim, is accused of having made fakes to benefit from state aid at the time of...

13 June 2022 Technology Networks

ProteoGenix, Aseem Healthcare and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2

ProteoGenix, Aseem Healthcare and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2. The...

Never miss news about ProteoGenix

Track ProteoGenix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ProteoGenix competitors & trending companies

Browse news for competitors to ProteoGenix and other trending companies.